Our previous study demonstrated that upregulation of IDO1 shifted tryptophan metabolism away from 5-HT biosynthesis, contributing to the development of depression in chronic pain condition (Kim et al., 2012). This evidence concerns the gene IDO1 and depressive symptom measurement.